Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 1.01, 2.03, 9.01 · 8-K

IQVIA Holdings Inc.

IQVNYSEEQUITYCurrent

Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Item 1.01 Entry into a Material Definitive Agreement Notes Offering and Notes Indenture On September 23, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc., completed the issuance and sale of $2,000,000,000 in gross proceeds of 6.375% senior notes due 2034 (the “Notes”). The Notes were issued pursuant to an Indenture, dated September 23, 2026 (the “Indenture”), among the Issuer, U.S.…

Filed Sep 23, 2026Accepted Sep 23, 2026, 5:03 PM EDTCIK 1478242Accession 0001193125-26-399616
Share

Company context

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 94,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

Current securities

Recent company filings

  1. Other EventsSep 9, 2026
  2. 144 filingSep 2, 2026
  3. 4 filingAug 4, 2026
  4. 4 filingJul 31, 2026
  5. 144 filingJul 29, 2026

Registered securities in this filing

IQVIA HOLDINGS INC. · 8-K · Filed 2026-09-23

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.01 per share

Symbol
IQV
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: duration_2026-09-23_to_2026-09-23

Dimensions: Not supplied

Accession 000119312526399616 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.01, 2.03, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01 Entry into a Material Definitive Agreement Notes Offering and Notes Indenture On September 23, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc., completed the issuance and sale of $2,000,000,000 in gross proceeds of 6.375% senior notes due 2034 (the “Notes”). The Notes were issued pursuant to an Indenture, dated September 23, 2026 (the “Indenture”), among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the Notes, and certain subsidiaries of the Issuer as guarantors. The net proceeds from the Notes offering will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes offering. The Notes are unsecured obligations of the Issuer, will mature on March 15, 2034, unless earlier repurchased or redeemed in accordance with their terms, and will bear interest at the rate of 6.375% per year, with interest payable semi-annually on March 15 and September 15 of each year, beginning on March 15, 2027. The Issuer may redeem the Notes prior to their final stated maturity, subject to a customary make-whole premium, at any time prior to September 15, 2029 (subject to a customary “equity claw” redemption right) and thereafter subject to a redemption premium declining from 3.188% to 0.000%. The foregoing description of the Notes and the Indenture is qualified in its entirety by reference to the Indenture relating thereto, a copy of which is filed as Exhibit 4.1 to this Current Report on Form 8-K.
Item 2.03Item 2.03 - Creation of Direct Financial Obligation
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information set forth above under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.
Filed exhibits (1)
EX-4.1 (by filename) d128109dex41.htm

Exhibit 4.1 Execution Version INDENTURE Dated as of September 23, 2026 among IQVIA Inc., as Issuer, the Guarantors party hereto, U.S. Bank Trust Company, National Association, as Trustee 6.375% SENIOR NOTES DUE 2034 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 32 SECTION 1.03. Rules of Construction 32 SECTION 1.04. Acts of Holders 33 SECTION 1.05. Limited Condition Transactions 34 ARTICLE II THE NOTES SECTION 2.01. Form and Dating; Terms 35 SECTION 2.02. Execution and Authentication

Open exhibit ↗